ibopamine has been researched along with fenoldopam in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girbes, AR; Smit, AJ; van Veldhuisen, DJ | 1 |
| Casagrande, C; La Regina, A; Merlo, L | 1 |
| Carey, RA; Jacob, L | 1 |
| Hasenfuss, G; Just, H | 1 |
| Goldberg, LI; Rajfer, SI | 1 |
| Nichols, AJ; Ruffolo, RR; Shebuski, RJ; Smith, JM | 1 |
| Blaine, EH; Seymour, AA | 1 |
| Smit, AJ | 1 |
| Felder, RA; Jose, PA; Zeng, C | 1 |
5 review(s) available for ibopamine and fenoldopam
| Article | Year |
|---|---|
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Deoxyepinephrine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1990 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Chronic Disease; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Vasodilator Agents | 1989 |
Dopamine in heart failure and critical care.
Topics: Cardiotonic Agents; Controlled Clinical Trials as Topic; Critical Care; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; Heart Failure; Hemodynamics; Humans; Treatment Outcome | 2000 |
A new approach for treatment of hypertension: modifying D1 dopamine receptor function.
Topics: Antihypertensive Agents; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; G-Protein-Coupled Receptor Kinase 4; GTP-Binding Proteins; Humans; Hypertension; Protein Serine-Threonine Kinases; Receptors, Dopamine D1; Renin-Angiotensin System | 2006 |
4 other study(ies) available for ibopamine and fenoldopam
| Article | Year |
|---|---|
Dopamine agonists, a new perspective in cardiovascular therapy?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic | 1991 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopam; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Dopamine; Structure-Activity Relationship; Vascular Resistance | 1985 |
Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Topics: Anesthesia; Animals; Benzazepines; Blood Vessels; Cardiotonic Agents; Deoxyepinephrine; Dogs; Dopamine; Female; Fenoldopam; Male; Receptors, Dopamine; Renal Circulation; Vascular Resistance | 1987 |
A comparison of some renal and cardiovascular effects of a prostaglandin analog, SKF 82526 and ibopamine in anesthetized dogs.
Topics: Anesthesia; Animals; Benzazepines; Blood Pressure; Deoxyepinephrine; Dogs; Dopamine; Electrolytes; Female; Fenoldopam; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; Phenoxybenzamine; Renal Circulation; Thiazoles; Thiazolidines; Vasodilator Agents | 1984 |